RAG2 and immunodeficiency disease: In humans, mutations in RAG1 or RAG2 result in various degrees of residual V(D)J recombination activity, causing a broad spectrum of clinical phenotypes, ranging from severe combined immunodeficiency to autoimmunity (Notarangelo et al. 2016; Delmonte et al. 2018).